{{Rsnum
|rsid=6490525
|Gene=GJA3
|Chromosome=13
|position=20162077
|Orientation=plus
|GMAF=0.04729
|Gene_s=GJA3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 97.7 | 2.3 | 0.0
| YRI | 60.5 | 36.1 | 3.4
| ASW | 73.7 | 26.3 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 93.1 | 6.9 | 0.0
| LWK | 60.9 | 34.5 | 4.5
| MEX | 96.6 | 3.4 | 0.0
| MKK | 72.4 | 26.3 | 1.3
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22864933
  |Trait=Capecitabine sensitivity
  |Title=Identification of novel germline polymorphisms governing capecitabine sensitivity.
  |RiskAllele=
  |Pval=4E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}